Doxorubicin Market – Biomarker-Guided Therapy Optimizing...

toegevoegd een audio Health

2026-09-07 09:46:14 -

Doxorubicin Market – Biomarker-Guided Therapy Optimizing Patient Selection

Market Overview Biomarker-guided therapy is optimizing patient selection in the doxorubicin market by identifying patients most likely to benefit from anthracycline treatment while sparing those at high risk for cardiotoxicity or treatment resistance. Genetic, molecular, and imaging biomarkers enable personalized doxorubicin therapy decisions. The Doxorubicin Market incorporates biomarker...

0 Reacties 0 aandelen 16 Views 0 voorbeeld